JP2006512097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512097A5 JP2006512097A5 JP2005510053A JP2005510053A JP2006512097A5 JP 2006512097 A5 JP2006512097 A5 JP 2006512097A5 JP 2005510053 A JP2005510053 A JP 2005510053A JP 2005510053 A JP2005510053 A JP 2005510053A JP 2006512097 A5 JP2006512097 A5 JP 2006512097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nucleic acid
- ctla
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43626802P | 2002-12-23 | 2002-12-23 | |
| US46660703P | 2003-04-30 | 2003-04-30 | |
| PCT/US2003/041053 WO2004058801A2 (en) | 2002-12-23 | 2003-12-22 | Modified vaccinia ankara expressing p53 in cancer immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512097A JP2006512097A (ja) | 2006-04-13 |
| JP2006512097A5 true JP2006512097A5 (enExample) | 2007-02-15 |
Family
ID=32685446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005510053A Withdrawn JP2006512097A (ja) | 2002-12-23 | 2003-12-22 | 癌免疫療法におけるｐ５３を発現する改変・ワクシニア・アンカラ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7256037B2 (enExample) |
| EP (1) | EP1575611A4 (enExample) |
| JP (1) | JP2006512097A (enExample) |
| AU (1) | AU2003297499A1 (enExample) |
| CA (1) | CA2511625A1 (enExample) |
| WO (1) | WO2004058801A2 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
| US20060246123A1 (en) * | 2003-03-12 | 2006-11-02 | Eli Gilboa | Oligonucleotide mimetics |
| US7674456B2 (en) * | 2004-06-14 | 2010-03-09 | Charles Wiseman | Breast cancer cell lines and uses thereof |
| NO347468B1 (no) | 2005-02-23 | 2023-11-13 | Bavarian Nordic As | Et modifisert Vacciniavirus Ankara (MVA) for anvendelse ved immunisering. |
| CN101268101A (zh) * | 2005-07-07 | 2008-09-17 | 科利制药集团公司 | 用于癌症治疗的抗-CTLA-4抗体和含有CpG基序的合成寡脱氧核苷酸联合治疗 |
| CN1919873B (zh) * | 2005-08-25 | 2012-05-30 | 北京沙东生物技术有限公司 | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 |
| JP6092497B2 (ja) | 2006-03-30 | 2017-03-08 | ユニバーシティー オブ カリフォルニア | 抗ｃｔｌａ−４抗体の限局性分泌のための方法および組成物 |
| US20090035360A1 (en) * | 2007-05-24 | 2009-02-05 | Dominique Ingrid Lemoine | Lyophilised antigen composition |
| US7998488B2 (en) * | 2008-11-14 | 2011-08-16 | Baxter International Inc. | Vaccine formulations and uses thereof |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| EP3082853A2 (en) | 2013-12-20 | 2016-10-26 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
| WO2016100977A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute Inc. | Methods for profiling the t-cel- receptor repertoire |
| WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
| WO2016128542A1 (en) | 2015-02-13 | 2016-08-18 | Transgene Sa | Immunotherapeutic vaccine and antibody combination therapy |
| WO2016144564A2 (en) | 2015-02-25 | 2016-09-15 | Memorial Sloan-Kettering Cancer Center | Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors |
| CN107847534B (zh) * | 2015-04-17 | 2022-10-04 | 纪念斯隆凯特琳癌症中心 | Mva或mvaδe3l作为抗实体瘤的免疫治疗剂的应用 |
| CR20200476A (es) | 2015-05-20 | 2020-12-02 | Dana Farber Cancer Inst Inc | ANTÍGENOS COMPARTIDOS (Divisional 2017-0584) |
| CN108884159A (zh) * | 2015-11-07 | 2018-11-23 | 茂体外尔公司 | 用于癌症治疗的包含肿瘤抑制基因治疗和免疫检查点阻断的组合物 |
| SG11201807051VA (en) | 2016-02-25 | 2018-09-27 | Memorial Sloan Kettering Cancer Center | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human flt3l or gm-csf for cancer immunotherapy |
| IL261321B2 (en) | 2016-02-25 | 2023-12-01 | Memorial Sloan Kettering Cancer Center | Recombinant MVA or MVADELE3L expressing human FLT3L and their use as immunotherapeutic agents against solid tumors |
| WO2018107011A1 (en) * | 2016-12-08 | 2018-06-14 | City Of Hope | P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof |
| EP3551226A1 (en) * | 2016-12-12 | 2019-10-16 | MultiVir Inc. | Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases |
| US20200085758A1 (en) | 2016-12-16 | 2020-03-19 | The Brigham And Women's Hospital, Inc. | Co-delivery of nucleic acids for simultaneous suppression and expression of target genes |
| WO2018140391A1 (en) | 2017-01-24 | 2018-08-02 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| WO2018209315A1 (en) | 2017-05-12 | 2018-11-15 | Memorial Sloan Kettering Cancer Center | Vaccinia virus mutants useful for cancer immunotherapy |
| US20210177964A1 (en) * | 2017-11-06 | 2021-06-17 | Memorial Sloan Kettering Cancer Center | Heat-inactivated vaccinia virus as a vaccine immune adjuvant |
| AU2019322487B2 (en) | 2018-03-19 | 2024-04-18 | Multivir Inc. | Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer |
| CN116162654A (zh) | 2018-09-15 | 2023-05-26 | 纪念斯隆凯特琳癌症中心 | 用于癌症免疫疗法的重组痘病毒 |
| US12274784B2 (en) | 2018-10-12 | 2025-04-15 | Synergene Therapeutics, Inc. | Methods for reducing side effects of immunotherapy |
| WO2021113644A1 (en) | 2019-12-05 | 2021-06-10 | Multivir Inc. | Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer |
| KR20230028484A (ko) * | 2020-06-24 | 2023-02-28 | 피엠브이 파마슈티컬스 인코포레이티드 | 암의 치료를 위한 병용 요법 |
| CN115537399B (zh) * | 2022-09-22 | 2025-02-11 | 沈阳药科大学 | 修饰化外泌体及其制法和外泌体联合pd-1抗体的原位喷雾水凝胶和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341245C (en) * | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
| US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US6045802A (en) * | 1994-10-03 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule |
| CN1723285B (zh) * | 2003-02-18 | 2013-01-02 | 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 | 重组的mva及其产生方法 |
-
2003
- 2003-12-22 WO PCT/US2003/041053 patent/WO2004058801A2/en not_active Ceased
- 2003-12-22 CA CA002511625A patent/CA2511625A1/en not_active Abandoned
- 2003-12-22 JP JP2005510053A patent/JP2006512097A/ja not_active Withdrawn
- 2003-12-22 AU AU2003297499A patent/AU2003297499A1/en not_active Abandoned
- 2003-12-22 EP EP03814346A patent/EP1575611A4/en not_active Withdrawn
- 2003-12-23 US US10/746,558 patent/US7256037B2/en not_active Expired - Lifetime
-
2007
- 2007-05-21 US US11/805,180 patent/US7563448B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512097A5 (enExample) | ||
| KR100767554B1 (ko) | 암 억제 유전자 더블유티1의 생산물에 기초한 암항원 | |
| RU2016109939A (ru) | Способ повышения экспрессии кодируемых рнк белков | |
| JP2008539187A5 (enExample) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| US11478544B2 (en) | Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes | |
| JP2002542827A5 (enExample) | ||
| HRP20201873T1 (hr) | Sredstva i postupci za liječenje hbv-a | |
| KR20180038465A (ko) | Ｂ형 간염 바이러스 감염에 대한 ｒｎａｉ 치료법 | |
| TW201408309A (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| JP2003530872A5 (enExample) | ||
| WO2014063601A1 (zh) | 诱导肿瘤特异性免疫的疫苗及其应用 | |
| MY209484A (en) | Cpg amphiphiles and uses thereof | |
| WO2004085645A1 (en) | Rna interference in fish | |
| KR20220042116A (ko) | B형 간염 바이러스(HBV) 백신 및 HBV-타케팅 RNAi의 조합 | |
| WO2018232353A4 (en) | Bacterial vaccine | |
| CN101287487A (zh) | 基于使用纤连蛋白eda结构域的试剂和方法 | |
| RU2004134331A (ru) | Антиген muc1 со сниженным числом повторяющихся vntr-блоков | |
| WO2003051454A3 (en) | Methods for particle-assisted polynucleotide immunization using a pulsed electric field | |
| WO2003031469A2 (de) | Mittel zur verbesserung der immunantwort | |
| WO2015042187A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| KR101329348B1 (ko) | 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스 | |
| CN1814757B (zh) | 一种CpGDNA新型佐剂及其制造方法和含有该佐剂的疫苗 | |
| RU98112608A (ru) | Иммуногенная композиция [на основе] tlp | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 |